.svg?rev=a492cc1069df46bdab38f8cb66573f1c&hash=2617C9FE8A7B0BD1C43269B5D5ED9AE2)
False Claims Act Defense & Compliance Counseling
Overview
Faegre Drinker’s Chambers USA-ranked attorneys are relied on by hundreds of health and life sciences sector companies, insurers, investors, and individuals for advice and representation on all types of fraud and abuse, and ethics and compliance matters, including civil and criminal enforcement defense and regulatory compliance counseling. In addition to developing state-of-the-art compliance programs that leverage existing resources to optimize compliance metrics and outcomes, we defend companies and executives that are subjects of investigations by federal and/or state law enforcement and regulatory authorities. We litigate high-stakes health care fraud cases for our clients, and we take cases to trial when it makes sense to do so. Our attorneys are well versed in the federal Anti-Kickback Statute and state equivalents; the Stark Law; federal procurement and reimbursement regulations; HHS-OIG guidance and opinions; government contracts statutory, regulatory, and administrative compliance and investigations; and, of course, all aspects of the False Claims Act. We routinely assess and resolve regulatory and compliance risks, guiding health care and life sciences clients through government investigations, federal and state health care fraud allegations, qui tam and whistleblower suits, voluntary disclosures, Medicare and Medicaid reimbursement audits, and program repayments.
Our deep bench of attorneys in this area includes seasoned defense attorneys, former compliance officers, three former US Attorneys, and multiple former federal and state prosecutors, including those who served as federal health care fraud coordinators. This experience informs our strategic approach to negotiations with, and litigation against, federal and state law enforcement agencies. Informed by experience and recognized for our track record of wins, Faegre Drinker delivers peace of mind for health care and life sciences clients faced with an evolving, risky enforcement environment.
